{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:35:18Z","timestamp":1793378118152,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.rmed.2026.109009","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:20:54Z","timestamp":1784042454000},"page":"109009","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The PEACE-24 study: Tezepelumab improves exercise tolerance and symptoms control in severe asthma"],"prefix":"10.1016","volume":"261","author":[{"given":"Benedetta","family":"Bondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Braido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pilo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Mincarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Riccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8244-9922","authenticated-orcid":false,"given":"Ilaria","family":"Baiardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ricchiuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3661-5731","authenticated-orcid":false,"given":"Diego","family":"Bagnasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"MAR","key":"10.1016\/j.rmed.2026.109009_bib1","article-title":"Pathophysiological mechanisms of asthma","volume":"7","author":"Bush","year":"2019","journal-title":"Front. Pediatr."},{"issue":"10118","key":"10.1016\/j.rmed.2026.109009_bib2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2026.109009_bib3","series-title":"GINA Strategy Report - Global Initiative for Asthma - GINA","year":"2026"},{"issue":"2","key":"10.1016\/j.rmed.2026.109009_bib4","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jaip.2019.08.050","article-title":"Dupilumab efficacy in patients with uncontrolled, moderate-to-severe allergic asthma","volume":"8","author":"Corren","year":"2020","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"2","key":"10.1016\/j.rmed.2026.109009_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.109009_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2024.102333","article-title":"Triple inhaled therapy in asthma: beliefs, behaviours and doubts","volume":"87","author":"Bagnasco","year":"2024","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.rmed.2026.109009_bib7","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/all.15076","article-title":"Single inhaler triple therapy (SITT) in asthma: systematic review and practice implications","volume":"77","author":"Agusti","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2026.109009_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/all.16569","article-title":"Burden of oral corticosteroid use in severe asthma: challenges and opportunities","author":"Canonica","year":"2025","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.rmed.2026.109009_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jaip.2023.11.007","article-title":"Efficacy and safety of biologics for oral corticosteroid-dependent asthma: a systematic review and network meta-analysis","volume":"12","author":"Phinyo","year":"2024","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"5","key":"10.1016\/j.rmed.2026.109009_bib10","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/all.15986","article-title":"Tezepelumab in patients with allergic and eosinophilic asthma","volume":"79","author":"Caminati","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2026.109009_bib11","doi-asserted-by":"crossref","first-page":"749","DOI":"10.2147\/JAA.S275039","article-title":"Targeting TSLP in asthma","volume":"15","author":"Parnes","year":"2022","journal-title":"J. Asthma Allergy"},{"issue":"1","key":"10.1016\/j.rmed.2026.109009_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-020-01505-x","article-title":"Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?","volume":"21","author":"Menzies-Gow","year":"2020","journal-title":"Respir. Res."},{"issue":"11","key":"10.1016\/j.rmed.2026.109009_bib13","doi-asserted-by":"crossref","first-page":"5972","DOI":"10.3390\/ijms25115972","article-title":"Thymic stromal lymphopoietin and tezepelumab in airway diseases: from physiological role to target therapy","volume":"25","author":"Bagnasco","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.rmed.2026.109009_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.alit.2020.01.001","article-title":"Anti-TSLP antibodies: targeting a master regulator of type 2 immune responses","volume":"69","author":"Nakajima","year":"2020","journal-title":"Allergol. Int."},{"issue":"9","key":"10.1016\/j.rmed.2026.109009_bib15","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1080\/17460441.2023.2230885","article-title":"An overview of the preclinical discovery and development of tezepelumab for the treatment of asthma","volume":"18","author":"Matera","year":"2023","journal-title":"Expert Opin. Drug Discov."},{"issue":"1","key":"10.1016\/j.rmed.2026.109009_bib16","first-page":"1","article-title":"Positioning of tezepelumab in severe asthma","volume":"34","author":"Miralles-L\u00f3pez","year":"2024","journal-title":"J Investig. Allergol. Clin. Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2026.109009_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02202-2022","article-title":"Not just an anti-eosinophil drug: tezepelumab treatment for type 2 asthma and beyond","volume":"61","author":"Corren","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.109009_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01296-2021","article-title":"The effect of tezepelumab on airway hyperresponsiveness to mannitol in asthma (UPSTREAM)","volume":"59","author":"Sverrild","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.rmed.2026.109009_bib19","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S2213-2600(21)00226-5","article-title":"Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"9","author":"Diver","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.109009_bib20","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1152\/japplphysiol.00216.2018","article-title":"Exertional dyspnea and operating lung volumes in asthma","volume":"125","author":"Moore","year":"2018","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.rmed.2026.109009_bib21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.rmed.2016.06.003","article-title":"Activity limitation and exertional dyspnea in adult asthmatic patients: what do we know?","volume":"117","author":"Vermeulen","year":"2016","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2026.109009_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030706","article-title":"Physical activity: a missing link in asthma care","volume":"9","author":"Panagiotou","year":"2020","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.rmed.2026.109009_bib23","article-title":"Effects of physical exercises in asthma: an umbrella review of systematic review and meta-analysis","volume":"19","author":"Huang","year":"2025","journal-title":"Clin. Res. J"},{"issue":"172","key":"10.1016\/j.rmed.2026.109009_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0238-2023","article-title":"Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials","volume":"33","author":"Kyriakopoulos","year":"2024","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2026.109009_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108551","article-title":"Biologics for severe asthma and beyond","volume":"252","author":"M\u00fcmmler","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.rmed.2026.109009_bib26","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.109009_bib27","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1164\/rccm.9120-11ST","article-title":"An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications","volume":"184","author":"Dweik","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2026.109009_bib28","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1183\/09031936.00150314","article-title":"An official european respiratory society\/american thoracic society technical standard: field walking tests in chronic respiratory disease","volume":"44","author":"Holland","year":"2014","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.rmed.2026.109009_bib29","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1183\/13993003.00853-2015","article-title":"A summary of the new GINA strategy: a roadmap to asthma control","volume":"46","author":"Reddel","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2026.109009_bib30","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.jaip.2018.02.027","article-title":"A systematic review of associations of physical activity and sedentary time with asthma outcomes","volume":"6","author":"Cordova-Rivera","year":"2018","journal-title":"J. Allergy Clin. Immunol. Pract."},{"issue":"11","key":"10.1016\/j.rmed.2026.109009_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187668","article-title":"The influence of physical activity, sedentary behavior on health-related quality of life among the general population of children and adolescents: a systematic review","volume":"12","author":"Wu","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.rmed.2026.109009_bib32","series-title":"Dietary Supplements Use in Competitive and Non-competitive Boxer: an Exploratory Study","author":"Blasio","year":"2016"},{"issue":"1","key":"10.1016\/j.rmed.2026.109009_bib33","first-page":"1","article-title":"A real life asthma biologic treatment comparison","volume":"6","author":"C\u00e1rdenas Contreras","year":"2025","journal-title":"J Allergy Infect Dis."},{"issue":"1","key":"10.1016\/j.rmed.2026.109009_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/resp.13719","article-title":"Incremental shuttle walking test in patients with asthma: shedding light on its measurement properties","volume":"25","author":"Boutou","year":"2020","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.rmed.2026.109009_bib35","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.pulmoe.2022.10.011","article-title":"Test-retest reliability, construct validity and determinants of 6-minute walk test performance in adult patients with asthma","volume":"29","author":"Meys","year":"2023","journal-title":"Pulmonology"},{"issue":"suppl 65","key":"10.1016\/j.rmed.2026.109009_bib36","article-title":"Reliability, construct validity and determinants of 6-minute walk distance in patients with asthma","volume":"58","author":"Meys","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2026.109009_bib37","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4187\/respcare.06112","article-title":"Reliability of cardiorespiratory and metabolic responses during incremental shuttle walk test in adult subjects with asthma","volume":"64","author":"Labadessa","year":"2019","journal-title":"Respir. Care"},{"issue":"1","key":"10.1016\/j.rmed.2026.109009_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ageing\/25.1.12","article-title":"Respiratory rehabilitation, exercise capacity and quality of life in chronic airways disease in old age","volume":"25","author":"Roomi","year":"1996","journal-title":"Age Ageing"},{"issue":"2","key":"10.1016\/j.rmed.2026.109009_bib39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/pri.428","article-title":"Six-minute walk test in Obese children and adolescents: reproducibility and validity","volume":"14","author":"Morinder","year":"2009","journal-title":"Physiother. Res. Int."},{"issue":"2","key":"10.1016\/j.rmed.2026.109009_bib40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1378\/chest.123.2.387","article-title":"The 6-min walk test: a quick measure of functional status in elderly adults","volume":"123","author":"Enright","year":"2003","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.rmed.2026.109009_bib41","first-page":"839","article-title":"Is the six-minute walk test correlated with disease control and quality of life in children with asthma?","volume":"42","author":"Y\u00fcksel","year":"2012","journal-title":"Turk. J. Med. Sci."},{"issue":"suppl 62","key":"10.1016\/j.rmed.2026.109009_bib42","article-title":"Comparison of sit-to-stand test and six-minute walk test in asthmatic and healthy children","volume":"52","author":"Kahraman","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2026.109009_bib43","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00114-2023","article-title":"Using the 6-min walk test to assess the clinical response to mepolizumab and conventional therapy in severe eosinophilic asthma","volume":"9","author":"Lombardi","year":"2023","journal-title":"ERJ Open Res"},{"issue":"3","key":"10.1016\/j.rmed.2026.109009_bib44","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5588\/ijtld.20.0928","article-title":"Minimal clinically important difference of the 6-min walking test in patients with asthma","volume":"25","author":"Zampogna","year":"2021","journal-title":"Int. J. Tubercul. Lung Dis."},{"issue":"4","key":"10.1016\/j.rmed.2026.109009_bib45","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01500-2018","article-title":"Dynamic hyperinflation impairs daily life activity in asthma","volume":"53","author":"van der Meer","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.rmed.2026.109009_bib46","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00738-2020","article-title":"Targeting dynamic hyperinflation in moderate-to-severe asthma: a randomised controlled trial","volume":"7","author":"van der Meer","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.rmed.2026.109009_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1611168","article-title":"The effects of benralizumab on lung volume changes during exercise in experimental setting in severe asthmatics: a pilot study","volume":"16","author":"Benfante","year":"2025","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.rmed.2026.109009_bib48","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1007\/s12325-023-02659-y","article-title":"Effect of tezepelumab on lung function in patients with severe, uncontrolled asthma in the phase 3 NAVIGATOR study","volume":"40","author":"Menzies-Gow","year":"2023","journal-title":"Adv. Ther."},{"issue":"6","key":"10.1016\/j.rmed.2026.109009_bib49","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00316-2024","article-title":"Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies","volume":"64","author":"Wechsler","year":"2024","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.rmed.2026.109009_bib50","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300135","article-title":"Tezepelumab and mucus plugs in patients with moderate-to-severe asthma","volume":"2","author":"Nordenmark","year":"2023","journal-title":"NEJM Evid."},{"issue":"suppl 68","key":"10.1016\/j.rmed.2026.109009_bib51","article-title":"Tezepelumab reduces the expression of MUC5AC in patients with asthma","volume":"64","author":"Norheim","year":"2024","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2026.109009_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01630","article-title":"Physical activity as a new tool to evaluate the response to omalizumab and mepolizumab in severe asthmatic patients: a pilot study","volume":"10","author":"Carpagnano","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.rmed.2026.109009_bib53","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1111\/all.16590","article-title":"Clinical and biological remission with tezepelumab: the real-world response in severe uncontrolled asthma","volume":"80","author":"Gates","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.rmed.2026.109009_bib54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/JAA.S342391","article-title":"Tezepelumab for severe asthma: one drug targeting multiple disease pathways and patient types","volume":"17","author":"Panettieri","year":"2024","journal-title":"J. Asthma Allergy"},{"issue":"suppl 66","key":"10.1016\/j.rmed.2026.109009_bib55","first-page":"1835","article-title":"Efficacy of tezepelumab according to age at asthma onset in NAVIGATOR","volume":"60","author":"Brusselle","year":"2022","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2026.109009_bib56","doi-asserted-by":"crossref","first-page":"169","DOI":"10.15586\/aei.v53i2.1326","article-title":"Real-life effectiveness of tezepelumab in severe asthma","volume":"53","author":"Miralles-L\u00f3pez","year":"2025","journal-title":"Allergol. Immunopathol."},{"issue":"8","key":"10.1016\/j.rmed.2026.109009_bib57","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/jcph.2433","article-title":"Population pharmacokinetic modeling and exposure\u2013efficacy and body weight\u2013response analyses for tezepelumab in patients with severe, uncontrolled asthma","volume":"64","author":"Zheng","year":"2024","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.rmed.2026.109009_bib58","first-page":"314","article-title":"Real- world evidence of tezepelumab for severe asthma - a retrospective multicenter cohort","author":"Khateeb","year":"2025","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.rmed.2026.109009_bib59","doi-asserted-by":"crossref","first-page":"A270.2","DOI":"10.1136\/thorax-2024-BTSabstracts.430","article-title":"M2\u2005Real world effectiveness of tezepelumab for adolescents and young adults with severe asthma","author":"Thomson","year":"2024","journal-title":"\u2018Into Thin Air\u2019 \u2013 From primary care to biologics"},{"issue":"32","key":"10.1016\/j.rmed.2026.109009_bib60","article-title":"The efficacy and safety of tezepelumab in the treatment of uncontrolled asthma: a systematic review and meta-analysis of randomized controlled trials","volume":"102","author":"Lin","year":"2023","journal-title":"Med. UK Ed."},{"issue":"1","key":"10.1016\/j.rmed.2026.109009_bib61","first-page":"1","article-title":"Safety and efficacy of tezepelumab vs. placebo in adult patients with severe uncontrolled asthma: a systematic review and meta-analysis","volume":"12","author":"Shaban","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.rmed.2026.109009_bib62","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.alit.2022.07.004","article-title":"Efficacy and safety of tezepelumab in patients recruited in Japan who participated in the phase 3 NAVIGATOR study","volume":"72","author":"Ishizuka","year":"2023","journal-title":"Allergol. Int."},{"issue":"19","key":"10.1016\/j.rmed.2026.109009_bib63","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJMoa2034975","article-title":"Tezepelumab in adults and adolescents with severe, uncontrolled asthma","volume":"384","author":"Menzies-Gow","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.rmed.2026.109009_bib64","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/02770900500498584","article-title":"Barriers and facilitators to healthy physical activity in asthma patients","volume":"43","author":"Mancuso","year":"2006","journal-title":"J. Asthma"},{"issue":"10","key":"10.1016\/j.rmed.2026.109009_bib65","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1056\/NEJMoa1704064","article-title":"Tezepelumab in adults with uncontrolled asthma","volume":"377","author":"Corren","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.rmed.2026.109009_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12050960","article-title":"Evaluation of clinical remission in best-performing severe asthmatic patients treated for three years with mepolizumab","volume":"12","author":"Bagnasco","year":"2024","journal-title":"Biomedicines"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112600377X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112600377X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:43:50Z","timestamp":1793375030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095461112600377X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":66,"alternative-id":["S095461112600377X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109009","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The PEACE-24 study: Tezepelumab improves exercise tolerance and symptoms control in severe asthma","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2026.109009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109009"}}